Johnson & Johnson Share Price BOERSE MUENCHEN

Equities

JNJ

US4781601046

Pharmaceuticals

Market Closed - BOERSE MUENCHEN 01:27:48 15/05/2024 am IST 5-day change 1st Jan Change
140 EUR -0.07% Intraday chart for Johnson & Johnson +1.55% -1.05%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 88.37B 81.64B 7,376B Sales 2025 * 90.78B 83.87B 7,577B Capitalization 364B 337B 30,409B
Net income 2024 * 22.04B 20.36B 1,840B Net income 2025 * 23.09B 21.33B 1,927B EV / Sales 2024 * 4.04 x
Net cash position 2024 * 7B 6.46B 584B Net cash position 2025 * 21.07B 19.47B 1,759B EV / Sales 2025 * 3.78 x
P/E ratio 2024 *
16.8 x
P/E ratio 2025 *
15.9 x
Employees -
Yield 2024 *
3.19%
Yield 2025 *
3.33%
Free-Float 77.07%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Johnson & Johnson

1 week+1.39%
Current month+3.35%
1 month+0.98%
3 months-3.50%
6 months+3.34%
Current year-1.12%
More quotes
1 week
138.02
Extreme 138.02
140.68
1 month
134.38
Extreme 134.38
142.48
3 years
131.44
Extreme 131.44
178.20
5 years
102.56
Extreme 102.56
178.20
10 years
73.07
Extreme 73.07
178.20
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 01/89/01
Director of Finance/CFO 57 01/98/01
Chief Tech/Sci/R&D Officer 58 05/19/05
Members of the board TitleAgeSince
Director/Board Member 70 25/19/25
Director/Board Member 72 19/14/19
Director/Board Member 70 22/09/22
More insiders
Date Price Change
14/24/14 140 -0.07%
13/24/13 140.1 +0.70%
10/24/10 139.1 +0.22%
09/24/09 138.8 +0.10%
08/24/08 138.7 +0.43%

Real-time BOERSE MUENCHEN, May 15, 2024 at 01:27 am IST

More quotes
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
151.4 USD
Average target price
173.3 USD
Spread / Average Target
+14.46%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW